Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More
Drugs Health Medical Pharma

Galleri test to detect multiple cancers rings in new hope

HQ Team June 3, 2023: A blood test accurately predicted two out of three cancers and their origins during a National Health Service.

Read More
Drugs Health Medical Pharma

Researchers unveil new magnet-controlled ingestible video capsules for endoscopy

HQ Team June 2, 2023: In a first, researchers at George Washington University have used an external magnet to remotely control ingestible video.

Read More
Drugs Health Medical Pharma

Global risk of cholera continues to be ‘very high’: WHO

HQ Team June 2, 2023: Shortage of oral vaccines and overstretched public health and medical professionals are contributing to the spread of cholera,.

Read More
Drugs Health Medical Pharma

Pfizer: ’Positive results’ emerge out of multi-drug-resistant trials

HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.

Read More
Drugs Health Medical Pharma

WHO unveils online repository of 450 psychoactive drugs

HQ Team June 1, 2023: The World Health Organization has posted a repository of more than 450 psychoactive drugs listing their abuses, harms,.

Read More
Drugs Health Medical Pharma

France reports a rapid rise in severe neonatal sepsis since July 2022

HQ Team June 1, 2023: Seven newborns have died in France due to severe neonatal sepsis associated with enterovirus during the more than.

Read More
Drugs Health Medical Pharma

Pfizer’s hemophilia trial cure shows 92% cut in bleeds

Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.

Read More
Drugs Health Pharma

FDA approves Lexicon’s oral drug for heart failure, type 2 diabetes patients

INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as.

Read More
Drugs Health Medical Pharma

Adult people of color in US at 59% more risk of premature death, researchers say

HQ Team May 27, 2023: Adult people of colour in the US have 59% higher risk of premature deaths than their white counterparts,.

Read More